Amgen Inc
(CHIX:AMGd)
€
254.9
0 (0%)
Market Cap: 136.64 Bil
Enterprise Value: 186.03 Bil
PE Ratio: 33.80
PB Ratio: 18.85
GF Score: 67/100 Amgen Inc at Guggenheim Partners Healthcare Talks Oncology Days Transcript
Feb 12, 2021 / 05:30PM GMT
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
All right. Hello. I'm Michael Schmidt, senior biotech analyst with Guggenheim Securities, and it's my great pleasure to welcome Amgen to this year's Virtual Guggenheim Oncology Day.
With us today, we have Gregory Friberg, who is the Vice President of Global Development at Amgen; as well as Arvind Sood, who most of you know, who's heading up Investor Relations at Amgen. Welcome, guys, and thanks so much for joining us this year.
Gregory Friberg
Amgen Inc. - Head of Oncology Global Development
Thanks, Michael.
Arvind Sood
Amgen Inc. - VP of IR
Thank you, Michael.
Questions & Answers
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
I thought, in the interest of time, I will jump right into Q&A. Maybe a bigger picture question upfront. Oncology is obviously one of the biggest and fastest-growing
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot